Showing 661 - 680 results of 41,980 for search '(( 50 ((ng decrease) OR (mean decrease)) ) OR ( 16 ((we decrease) OR (a decrease)) ))', query time: 0.97s Refine Results
  1. 661
  2. 662
  3. 663

    S2 File - by Yosuke Kameno (342665)

    Published 2023
    “…Contrary to increasing new infected cases as waves progressed, initially elevated psychological distress (K6) and fear of COVID-19 (FCV-19S) were decreased among waves (K6: B = -.02, 95% confidence interval [CI] = -.03 to -.01; FCV-19S: B = -.10, 95% CI = -.16 to -.04). …”
  4. 664

    S1 File - by Yosuke Kameno (342665)

    Published 2023
    “…Contrary to increasing new infected cases as waves progressed, initially elevated psychological distress (K6) and fear of COVID-19 (FCV-19S) were decreased among waves (K6: B = -.02, 95% confidence interval [CI] = -.03 to -.01; FCV-19S: B = -.10, 95% CI = -.16 to -.04). …”
  5. 665
  6. 666

    Identifying radiation-induced survivorship syndromes affecting bowel health in a cohort of gynecological cancer survivors by Gunnar Steineck (226792)

    Published 2017
    “…<div><p>Background</p><p>During radiotherapy unwanted radiation to normal tissue surrounding the tumor triggers survivorship diseases; we lack a nosology for radiation-induced survivorship diseases that decrease bowel health and we do not know which symptoms are related to which diseases.…”
  7. 667
  8. 668
  9. 669
  10. 670
  11. 671

    Supplementary Material for: Decreased Blood Flow after Sorafenib Administration Is an Imaging Biomarker to Predict Overall Survival in Patients with Advanced Hepatocellular Carcino... by Arizumi T. (3588833)

    Published 2014
    “…<b><i>Results:</i></b> Statistically significant differences in OS were observed among the three groups (p < 0.001). A decrease or disappearance of arterial enhancement was significantly associated with improved OS compared to patients with no change in arterial enhancement; the median OS was 19.9 months (95% confidence interval, CI, 16.4-24.5 months) and 6.0 months (95% CI, 4.0-8.8 months), respectively (p < 0.001). …”
  12. 672

    Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer by Alexander Henke (145303)

    Published 2012
    “…In P28 and adult prostates there was either a decrease in the expression (Semaphorin6D) or a switch to epithelial expression of SPARC, and Spry-1, whereas Decorin and Tsukushi were specific to mesenchyme/stroma at all ages. …”
  13. 673
  14. 674
  15. 675
  16. 676
  17. 677
  18. 678
  19. 679
  20. 680